BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18433782)

  • 1. BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk.
    Zhu Y; Horikawa Y; Yang H; Wood CG; Habuchi T; Wu X
    J Urol; 2008 Jun; 179(6):2416-21. PubMed ID: 18433782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.
    Zhu Y; Spitz MR; Zheng YL; Hong WK; Wu X
    Cancer; 2002 Aug; 95(3):563-8. PubMed ID: 12209748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
    Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
    Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
    Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer.
    Gu J; Horikawa Y; Chen M; Dinney CP; Wu X
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
    Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
    J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
    Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
    Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
    Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
    Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
    Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck.
    Li D; Firozi PF; Chang P; Wang LE; Xiong P; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
    Int J Cancer; 2001 Aug; 93(3):436-40. PubMed ID: 11433411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
    Martinez A; Fullwood P; Kondo K; Kishida T; Yao M; Maher ER; Latif F
    Mol Pathol; 2000 Jun; 53(3):137-44. PubMed ID: 10897333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in 19q13.3 genes associated with alteration of repair capacity to BPDE-DNA adducts in primary cultured lymphocytes.
    Xiao M; Xiao S; Straaten TV; Xue P; Zhang G; Zheng X; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Zhu G; Lu X
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Dec; 812():39-47. PubMed ID: 27908386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck.
    Xiong P; Hu Z; Li C; Wang LE; El-Naggar AK; Sturgis EM; Wei Q
    Int J Cancer; 2007 Dec; 121(12):2735-40. PubMed ID: 17724733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
    Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.
    Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q
    Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal alterations and mutagen sensitivity in human mucosal cells of the oropharynx and lymphocytes caused by BPDE.
    Reiter M; Baumeister P; Zieger S; Harréus U
    Cancer Genomics Proteomics; 2009; 6(5):247-54. PubMed ID: 19996129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.